A new, non-invasive nasal swab test for kids that diagnoses specific asthma subtype, or endotype, could help clinicians prescribe medications more precisely and pave the way for research toward better ...

Severity of a COVID-19 illness could be determined by examining autoantibodies in the nasal cavity, allowing more personalized treatment protocols. Severe COVID-19 can be life-threatening for patients ...

PITTSBURGH (KDKA) — A nasal swab test could be a breakthrough for children with suspected sinus infections. The test could tell parents whether their child needs antibiotics for their sinus infection ...

A new paper describes a test that can differentiate between different types of asthma via a nasal swab. Researchers hope the test can eventually be used to help match patients with better treatments.

Scientists may have sniffed out a breakthrough when detecting Alzheimer’s. The degenerative disease, which affects millions of Americans and gradually destroys memory, thinking skills and the capacity ...

Researchers at the University of Pittsburgh have developed a nasal swab test for children and youth that helps clinicians diagnose specific asthma subtypes, or endotypes, using nasal epithelial gene ...

A new nasal swab test can accurately predict the severity of COVID-19 infections. It provides a more precise prediction than currently available of how serious the case is by focusing on ...

Not sure what's causing your child's asthma? A new quick-and-easy nasal swab test for kids can diagnose the specific immune system drivers behind their asthma, potentially opening the door to better ...

Diagnosing precisely what type of asthma a child has and fine-tuning the treatment for it involves an invasive procedure under general anesthesia. For children with mild asthma, it's just not worth ...

Add Yahoo as a preferred source to see more of our stories on Google. A new quick-and-easy nasal swab test for kids can diagnose the specific immune system drivers behind their asthma, potentially ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT) today announced new data showing that its Percepta Nasal Swab test accurately assesses lung cancer risk among current and ...